Literature DB >> 29453891

An investigation of an open-access model for scaling up methadone maintenance treatment.

Lynn M Madden1,2, Scott O Farnum2, Kathryn F Eggert2, Andrew R Quanbeck3, Robert M Freeman2, Samuel A Ball1,2, Richard S Schottenfeld1,2, Julia M Shi1,2, Mary Ellen Savage1,2, Declan T Barry1,2.   

Abstract

AIMS: To examine retrospectively patient and programmatic outcomes following the development and implementation of an 'open-access' model in which prospective patients were enrolled rapidly in methadone maintenance treatment, irrespective of ability to pay, and provided real-time access to multiple voluntary treatment options.
DESIGN: Medical and administrative records were abstracted to compare data for 1 year before and 9 years after initiating the implementation of an open-access treatment model in May 2007.
SETTING: Methadone maintenance treatment center in Connecticut, USA. PARTICIPANTS: Individuals with opioid use disorder entering treatment between July 2006 and June 2015. In June 2015, 64% (n = 2594) of the sample were men and 80% (n = 3133) reported that they were white. INTERVENTION: The Network for the Improvement of Addiction Treatment-informed open-access treatment model uses process improvement strategies to improve treatment access and capacity. MEASUREMENTS: Census, waiting time, retention, non-medical opioid use, patient mortality and financial sustainability (net income and state-block grants as proportions of revenue).
FINDINGS: In the 9 years following the initial implementation of the open-access model, patient census increased by 183% from 1431 to 4051, and average waiting-time days decreased from 21 to 0.3 (same day) without apparent deleterious effects on rates of retention, non-medical opioid use or mortality. Between fiscal years (FY) 06 and FY 15, net operating margin rose from 2 to 10%, while state-block grant revenues declined 14% and the proportion of total revenue from state-block grant revenue decreased from 49 to 24%.
CONCLUSIONS: An open-access model for rapid enrolment of people with opioid use disorder in methadone treatment appears to improve treatment access, capacity, and financial sustainability without evidence of deleterious effects on treatment outcomes.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  Access to health care; capacity building; implementation science; methadone; opioid-related disorders; program sustainability

Year:  2018        PMID: 29453891     DOI: 10.1111/add.14198

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  15 in total

1.  Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment.

Authors:  Stephen R Baldassarri; Mark Beitel; Andrey Zinchuk; Nancy S Redeker; David E Oberleitner; Lindsay M S Oberleitner; Danilo Carrasco; Lynn M Madden; Nathan Lipkind; David A Fiellin; Lori A Bastian; Kevin Chen; H Klar Yaggi; Declan T Barry
Journal:  Sleep Breath       Date:  2020-06-17       Impact factor: 2.816

2.  A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use.

Authors:  Brent A Moore; Frank D Buono; Daniel P Lloyd; Destiny M B Printz; David A Fiellin; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2018-11-24

3.  Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment.

Authors:  Stephen R Baldassarri; David A Fiellin; Mary Ellen Savage; Lynn M Madden; Mark Beitel; Lara K Dhingra; Lisa Fucito; Deepa Camenga; Pooja Bollampally; Declan T Barry
Journal:  Drug Alcohol Depend       Date:  2019-01-17       Impact factor: 4.492

4.  Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support.

Authors:  Dharushana Muthulingam; Joshua Bia; Lynn M Madden; Scott O Farnum; Declan T Barry; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2019-01-26

5.  Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.

Authors:  Alexei Zelenev; Portia Shea; Alyona Mazhnaya; Julia Rozanova; Lynn Madden; Ruthanne Marcus; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2018-06-30       Impact factor: 4.492

6.  Alexithymia and pain experience among patients using methadone-maintenance therapy.

Authors:  Kristen P Morie; Marc N Potenza; Mark Beitel; Lindsay M Oberleitner; Corey R Roos; Sarah W Yip; David E Oberleitner; Marina Gaeta; Declan T Barry
Journal:  Drug Alcohol Depend       Date:  2020-10-24       Impact factor: 4.492

7.  A qualitative investigation of addiction counselors' perceptions and experiences implementing an open-access model for treating opioid use disorder.

Authors:  Lindsay M S Oberleitner; Lynn M Madden; Dharushana Muthulingam; Ruthanne Marcus; David E Oberleitner; Mark Beitel; Marina Gaeta; Joseph F Tamberelli; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2020-11-02

8.  A Community Responds to the COVID-19 Pandemic: a Case Study in Protecting the Health and Human Rights of People Who Use Drugs.

Authors:  Robert Heimer; Ryan McNeil; David Vlahov
Journal:  J Urban Health       Date:  2020-08       Impact factor: 3.671

9.  "A good mother": Impact of motherhood identity on women's substance use and engagement in treatment across the lifespan.

Authors:  Zoe M Adams; Callie M Ginapp; Carolina R Price; Yilu Qin; Lynn M Madden; Kimberly Yonkers; Jaimie P Meyer
Journal:  J Subst Abuse Treat       Date:  2021-05-14

10.  Correlates of Homelessness Among Patients in Methadone Maintenance Treatment.

Authors:  Marina Gaeta; Mark Beitel; Lindsay M S Oberleitner; David E Oberleitner; Lynn M Madden; Joseph F Tamberelli; Declan T Barry
Journal:  Med Care       Date:  2020-11       Impact factor: 3.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.